Company News in the Life Science Industry

»

Reset 

Affordable Dentures & Implants® Opens New Practice In Speedway

SPEEDWAY, Ind., Nov. 20, 2017 /PRNewswire/ -- Charles Zasso, DDS and William Fowler, DDS have announced the opening of the newest affiliated Affordable Dentures & Implants® practice opened in... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017

NASA Astronaut Available for Interviews Before Space Station Mission

WASHINGTON, Nov. 20, 2017 /PRNewswire-USNewswire/ -- NASA astronaut Scott Tingle will be available at 6 a.m. EST Friday, Dec. 1 for live satellite interviews one last time prior to his upcoming... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017

American Osteopathic Association Names Daniel Williams, DO, Vice President of Certifying Board Services

CHICAGO, Nov. 20, 2017 /PRNewswire-USNewswire/ -- Daniel G. Williams, DO, was named vice president of certifying board services by the American Osteopathic Association (AOA).

Read more ››
By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  The American Osteopathic Association

The Brooklyn Hospital Center and Mount Sinai Heart Collaborate to Provide Comprehensive Cardiac Care in Downtown Brooklyn

BROOKLYN, N.Y., Nov. 20, 2017 /PRNewswire/ -- The Brooklyn Hospital Center (TBHC) and Mount Sinai Heart hosted a breakfast reception on November 16, to celebrate a clinical collaboration that provides access to comprehensive cardiac care in Downtown Brooklyn. The alliance makes it possible for... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  Icahn School of Medicine at Mount Sinai - Genomic Core | Icahn School of Medicine at Mount Sinai - Immunogenetics Core | Mount Sinai Innovation Partners

Summit Completes Initial 24 Weeks of Dosing of Ezutromid in Patients with DMD in PhaseOut DMD Clinical Trial

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017
Related companies:  Summit Therapeutics plc | Summit Medical Products, Inc. | Great Summit Co., Ltd. | Summit Biosciences Inc.

Shire plc : Directorate change

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017
Related companies:  ShangPharma Corp. (SHP)

NuCana plc to Participate in the Evercore ISI Biopharma Catalyst / Deep Dive Conference

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017
Related companies:  NuCana BioMed Limited

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017
Related companies:  Novo Nordisk A/S

Zealand increases its share capital as a consequence of exercise of employee warrants

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers

Read more ››
By: Nasdaq / GlobenewsWire - 20 Nov 2017
Related companies:  Medtronic Plc

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, 2018

NEW YORK, Nov. 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acorda Therapeutics, Inc. ("Acorda" or the "Company") (NASDAQ: ACOR) and certain of its officers, on behalf of a class who... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  Acorda Therapeutics, Inc.

ENA Applauds the Signing of Legislation Allowing EMS Personnel to Continue Administering Life-Saving Medication

DES PLAINES, Ill., Nov. 20, 2017 /PRNewswire-USNewswire/ -- The Emergency Nurses Association (ENA) applauds Congress for passing, and President Trump for signing into law, the Protecting Patient Access to Emergency... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017

Zubsolv® Receives Authorization for Treatment of Opioid Dependence in Europe

Uppsala, SWEDEN, November 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  Orexo AB

Mylan to Present at Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference

HERTFORDSHIRE, England and PITTSBURGH, Nov. 20, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its president, Rajiv Malik, will present at the Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference in Boston, Mass., on Thursday, Nov. 30, 2017, at 3:50 p.m. ET.... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  Mylan (UK)

Flow Chemistry Market - 9% Growth Forecast for the U.S. to 2024

OCEAN VIEW, Del., Nov. 20, 2017 /PRNewswire-iReach/ -- Global Flow Chemistry Market will be valued USD 2... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017

Legal Cannabis Medical Market Shows Strong Growth

NEW YORK, November 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  Corbus Pharmaceuticals Holdings, Inc. | Zynerba Pharmaceuticals, Inc. | Vitality Biopharma

Check-Cap Ltd. Announces $2.5 Million Registered Direct Offering

ISFIYA, Israel and BOSTON, Nov. 20, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017

BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine

NESS ZIONA, Israel, November 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Nov 2017

Mechanism of Action Studies for DNAtrix's Oncolytic Virus DNX-2401 Presented at the 2017 Society for Neuro-Oncology Annual Meeting

HOUSTON, Nov. 20, 2017 /PRNewswire/ -- DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced multiple studies detailing the mechanism and efficacy of DNX-2401 were presented at the 2017 Society for Neuro-Oncology (SNO) Annual Meeting, held in San Francisco,... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  DNAtrix, Inc.

ATCC develops novel in vitro model to investigate drug candidates for cancer metastasis

MANASSAS, Va., Nov. 20, 2017 /PRNewswire-USNewswire/ -- ATCC, an established and trusted source of biological materials in the R&D community, today announced the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer. This model... Read more ››

By: PR Newswire Association LLC. - 20 Nov 2017
Related companies:  American Type Culture Collection (ATCC)
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies